Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria
B Banwell, JL Bennett, R Marignier, HJ Kim… - The Lancet …, 2023 - thelancet.com
Serum antibodies directed against myelin oligodendrocyte glycoprotein (MOG) are found in
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
patients with acquired CNS demyelinating syndromes that are distinct from multiple sclerosis …
Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
Over the past few years, new-generation cell-based assays have demonstrated a robust
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
association of autoantibodies to full-length human myelin oligodendrocyte glycoprotein …
Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
P Waters, G Fadda, M Woodhall, J O'Mahony… - JAMA …, 2020 - jamanetwork.com
Importance Identifying the course of demyelinating disease associated with myelin
oligodendrocyte glycoprotein (MOG) autoantibodies is critical to guide appropriate treatment …
oligodendrocyte glycoprotein (MOG) autoantibodies is critical to guide appropriate treatment …
Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management
W Ambrosius, S Michalak, W Kozubski… - International journal of …, 2020 - mdpi.com
Myelin oligodendrocyte glycoprotein (MOG)-associated disease (MOGAD) is a rare,
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
antibody-mediated inflammatory demyelinating disorder of the central nervous system …
The clinical spectrum and incidence of anti-MOG-associated acquired demyelinating syndromes in children and adults
CL De Mol, YYM Wong, ED Van Pelt… - Multiple Sclerosis …, 2020 - journals.sagepub.com
Objectives: The aim of this study was to assess the Dutch nationwide incidence of myelin
oligodendrocyte glycoprotein (MOG)-IgG-associated acquired demyelinating syndromes …
oligodendrocyte glycoprotein (MOG)-IgG-associated acquired demyelinating syndromes …
[HTML][HTML] EU paediatric MOG consortium consensus: Part 1–Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated …
AL Bruijstens, C Lechner, L Flet-Berliac, K Deiva… - European Journal of …, 2020 - Elsevier
Over the past few years, increasing interest in the role of autoantibodies against myelin
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …
oligodendrocyte glycoprotein (MOG-abs) as a new candidate biomarker in demyelinating …
Treatment approaches for MOG-Ab-associated demyelination in children
Y Hacohen, B Banwell - Current treatment options in neurology, 2019 - Springer
Purpose of review The purpose of this review is to summarize current understanding
regarding the treatment of myelin oligodendrocyte glycoprotein antibody (MOG-Ab) …
regarding the treatment of myelin oligodendrocyte glycoprotein antibody (MOG-Ab) …